top of page

Birmingham Biotechnology Hub

  • Oct 26, 2023
  • 1 min read

By leveraging AI in tandem with representative data, the Hub will become a global center of excellence in drug, vaccine, and diagnostics development. It will address the unique needs of underrepresented patient segments, improve diagnostic accuracy and drug efficacy, reduce

timelines to develop new drugs and vaccines, enable rapid response to emerging health threats, and improve health outcomes of diverse patients at home and abroad.

 
 
 

Recent Posts

See All
SPARC and DBIDS Seminar Announcement

We are pleased to welcome Dr. Qing Shao from the University of Kentucky for a seminar on AI-driven protein modeling and molecular simulations . In this talk, Dr. Shao will discuss new approaches for

 
 
 

Comments


bottom of page